Octreotide / Somatostatin Receptor Scintigraphy

Octreotide / Somatostatin Receptor Scintigraphy is most useful when your doctor or other qualified clinician needs imaging of Neuroendocrine tumour receptors for functional radionuclide imaging. Please bring the referral or clinical question if one has been issued, because the exact protocol may depend on why this specific scan is being requested.

Nuclear-medicine preparation depends on the tracer and organ being studied. Tell the centre about pregnancy, breastfeeding and current medicines; you may receive specific hydration, fasting or medication-hold instructions. Bring your glasses, contact-lens information and current eye medications. Pupil-dilating drops may be used for some eye imaging, so temporary light sensitivity or blurred near vision is possible. For Octreotide / Somatostatin Receptor Scintigraphy specifically, follow any appointment message from the imaging centre because the final protocol can change with your clinical history and the exact question being investigated.

Please provide the clinical indication or referral question for Octreotide / Somatostatin Receptor Scintigraphy, relevant symptoms and duration, previous surgery or treatment involving Neuroendocrine tumour receptors, current medicines, allergies where relevant, and any previous imaging or reports that could help comparison.

At the appointment, staff will confirm your identity and the reason for Octreotide / Somatostatin Receptor Scintigraphy, position you appropriately and acquire images of Neuroendocrine tumour receptors. A small amount of radiotracer is administered and an uptake period may be required before imaging, so the total visit can be considerably longer than the scan itself.

This examination may involve ionising radiation; tell the facility if you are pregnant or think you could be pregnant so the benefit, timing and protocol can be reviewed. Breastfeeding instructions can vary with the radiotracer, so breastfeeding patients should notify the nuclear-medicine team in advance. The supervising team should complete the safety screen specifically for Octreotide / Somatostatin Receptor Scintigraphy before proceeding.

The images from Octreotide / Somatostatin Receptor Scintigraphy are reviewed by an appropriately qualified imaging specialist or clinician. The report should be interpreted together with your history, examination findings and other tests; an imaging result alone may not establish the final diagnosis. Urgent or unexpected findings may require faster clinical follow-up than the routine delivery time shown in this listing.

Please arrive early enough for registration and safety screening. The listed price for Octreotide / Somatostatin Receptor Scintigraphy is a starting market price and can change with contrast, sedation, additional sequences/views, radiologist subspecialty reporting, consumables or facility location. If your symptoms are severe or rapidly worsening, seek urgent clinical care rather than waiting for a routine imaging booking.